STERIS Cost of Goods Sold 2010-2024 | STE
STERIS annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- STERIS cost of goods sold for the quarter ending December 31, 2024 was $0.760B, a 3.06% increase year-over-year.
- STERIS cost of goods sold for the twelve months ending December 31, 2024 was $3.054B, a 15.76% increase year-over-year.
- STERIS annual cost of goods sold for 2024 was $2.921B, a 14.28% increase from 2023.
- STERIS annual cost of goods sold for 2023 was $2.556B, a 9.19% increase from 2022.
- STERIS annual cost of goods sold for 2022 was $2.34B, a 32.64% increase from 2021.
| STERIS Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $2,921 |
| 2023 | $2,556 |
| 2022 | $2,340 |
| 2021 | $1,764 |
| 2020 | $1,711 |
| 2019 | $1,607 |
| 2018 | $1,527 |
| 2017 | $1,587 |
| 2016 | $1,343 |
| 2015 | $1,076 |
| 2014 | $973 |
| 2013 | $881 |
| 2012 | $838 |
| 2011 | $761 |
| 2010 | $719 |
| 2009 | $772 |
| STERIS Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-12-31 | $760 |
| 2024-09-30 | $750 |
| 2024-06-30 | $707 |
| 2024-03-31 | $836 |
| 2023-12-31 | $738 |
| 2023-09-30 | $692 |
| 2023-06-30 | $654 |
| 2023-03-31 | $554 |
| 2022-12-31 | $694 |
| 2022-09-30 | $668 |
| 2022-06-30 | $639 |
| 2022-03-31 | $411 |
| 2021-12-31 | $671 |
| 2021-09-30 | $717 |
| 2021-06-30 | $542 |
| 2021-03-31 | $494 |
| 2020-12-31 | $463 |
| 2020-09-30 | $426 |
| 2020-06-30 | $382 |
| 2020-03-31 | $459 |
| 2019-12-31 | $443 |
| 2019-09-30 | $418 |
| 2019-06-30 | $391 |
| 2019-03-31 | $434 |
| 2018-12-31 | $409 |
| 2018-09-30 | $394 |
| 2018-06-30 | $370 |
| 2018-03-31 | $424 |
| 2017-12-31 | $384 |
| 2017-09-30 | $368 |
| 2017-06-30 | $352 |
| 2017-03-31 | $400 |
| 2016-12-31 | $389 |
| 2016-09-30 | $399 |
| 2016-06-30 | $398 |
| 2016-03-31 | $426 |
| 2015-12-31 | $381 |
| 2015-09-30 | $281 |
| 2015-06-30 | $256 |
| 2015-03-31 | $289 |
| 2014-12-31 | $276 |
| 2014-09-30 | $269 |
| 2014-06-30 | $243 |
| 2014-03-31 | $281 |
| 2013-12-31 | $242 |
| 2013-09-30 | $229 |
| 2013-06-30 | $221 |
| 2013-03-31 | $250 |
| 2012-12-31 | $227 |
| 2012-09-30 | $203 |
| 2012-06-30 | $200 |
| 2012-03-31 | $226 |
| 2011-12-31 | $217 |
| 2011-09-30 | $209 |
| 2011-06-30 | $186 |
| 2011-03-31 | $222 |
| 2010-12-31 | $191 |
| 2010-09-30 | $177 |
| 2010-06-30 | $171 |
| 2010-03-31 | $190 |
| 2009-12-31 | $188 |
| 2009-09-30 | $182 |
| 2009-06-30 | $159 |
| 2009-03-31 | $205 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.902B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $201.227B | 88.14 |
| Thermo Fisher Scientific (TMO) | United States | $163.300B | 19.75 |
| Alcon (ALC) | Switzerland | $46.755B | 31.08 |
| Edwards Lifesciences (EW) | United States | $43.878B | 28.77 |
| IDEXX Laboratories (IDXX) | United States | $40.977B | 47.09 |
| DexCom (DXCM) | United States | $33.349B | 51.54 |
| IQVIA Holdings (IQV) | United States | $27.010B | 15.13 |
| Mettler-Toledo (MTD) | United States | $24.411B | 29.03 |
| Waters (WAT) | United States | $21.820B | 30.79 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.782B | 0.00 |
| Hologic (HOLX) | United States | $13.106B | 14.24 |
| Penumbra (PEN) | United States | $11.523B | 90.44 |
| Sysmex ADR (SSMXY) | Japan | $11.349B | 0.00 |
| Masimo (MASI) | United States | $8.868B | 32.71 |
| Globus Medical (GMED) | United States | $8.116B | 19.03 |
| Teleflex (TFX) | United States | $5.711B | 9.43 |
| Glaukos (GKOS) | United States | $5.408B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.211B | 22.07 |
| TransMedics (TMDX) | United States | $4.016B | 87.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.012B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.466B | 14.69 |
| Veracyte (VCYT) | United States | $2.409B | 33.80 |
| Nihon Kohden (NHNKY) | Japan | $2.072B | 11.33 |
| Elekta AB (EKTAY) | Sweden | $1.983B | 17.83 |
| Alphatec Holdings (ATEC) | United States | $1.852B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.562B | 0.00 |
| Artivion (AORT) | United States | $1.229B | 115.08 |
| Pulse Biosciences (PLSE) | United States | $1.130B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.062B | 5.65 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.800B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.696B | 15.20 |
| IRadimed (IRMD) | United States | $0.668B | 33.92 |
| Beta Bionics (BBNX) | United States | $0.615B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| OrthoPediatrics (KIDS) | United States | $0.565B | 0.00 |
| RxSight (RXST) | United States | $0.559B | 0.00 |
| AxoGen (AXGN) | United States | $0.519B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.503B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.485B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.452B | 0.00 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.382B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.10 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.273B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.226B | 13.69 |
| 908 Devices (MASS) | United States | $0.205B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.197B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.163B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.126B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.075B | 11.38 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.25 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |